Skip to Content
Skip to main content
CenGEM

CenGEM

Defining and exploiting the role of non-genetic variability in cancer biology
Funder: Wellcome Trust / University of Cambridge Institutional Strategic Support Fund
Duration: January 2019 - June 2020

Personal Fellowship

Milking the Thistle
Funder: IEHS
Duration: August 2018 - February 2019

Assessing the bioreactive fraction of the thislte in DNA damage repair and ageing

Low-cost Portable Molecular Diagnostic Platform for Rapid Detection of Poultry Infectious Pathogens (LMDP)
Funder: Biotechnology & Biological Sciences Research Council
Duration: April 2018 - March 2021
Technician/Scientific Officer Support
Funder: Mount Vernon Cancer Centre
Duration: April 2018 - March 2019
Elucidation of the metabolic signature of Friedreich’s ataxia
Funder: FARA-US
Duration: April 2018 - June 2021
Integrating mitochondrial metabolism and gene expression regulation in acute myeloid leukaemia
Funder: Isaac Newton Trust / Wellcome Trust ISSF / University of Cambridge Joint Research Grants Scheme
Duration: March 2018 - February 2019

Salary and research costs Research Associate (Dr Rashmi Kulkarni)

Systematic Literature Review on Interactions in Chemical Mixtures
Funder: European Joint Research Centre
Duration: January 2018 - December 2018
Development of a study protocol for thyroid disruptor testing in the mammalian system
Funder: European Commission
Duration: January 2018 - June 2019
Development of a study protocol for thyroid disruptor testing in the mammalian system
Funder: European Commission Directorate-General for the Environment
Duration: December 2017 - February 2018
Modelling the t(7;12) infant leukaemia using Gene Editing Technology
Funder: Kidscan
Duration: October 2017 - October 2020
Modelling the t(7;12) Infant Leukaemia using Gene Editing Technology
Funder: Kidscan
Duration: October 2017 - September 2020
Towards an improved human risk assessment of pesticides on male reproductive health
Funder: Danish Environment Ministry
Duration: October 2017 - September 2020
PhD studentship: use of liquid biopsies as diagnostic and prognostic biomarkers for lung cancer
Funder: Mount Vernon Cancer Centre
Duration: October 2017 - September 2020
PhD studentship - GSK Charlotte Kay
Funder: GlaxoSmithKline
Duration: October 2017 - September 2023
The Role of Genetic, Epigenetic and Transcriptional Heterogeneities in Pre-leukaemia to Leukaemia Progression in AML
Funder: Lady Tata Memorial Trust
Duration: October 2017 - September 2020

PhD Studentship to Shikha Gupta (University of Cambridge)

Aged Veterans - Centre of Excellence
Funder: Nuclear Community Charity Fund
Duration: September 2017 - August 2020
Genomic assessment of nuclear test veterans and their families
Funder: Nuclear Community Charity Fund
Duration: September 2017 - August 2020
Radiation risks from high-LET alpha-emitters using radium-223 as a model.
Funder: Public Health England
Duration: August 2017 - July 2020
Microbiology Society Harry Smith Vacation Studentship 2017
Funder: Microbiology Society
Duration: July 2017 - August 2017
Linking Metabolism and Epigenetics in Acute Myeloid Leukaemia
Funder: Leuka (Leukaemia UK)
Duration: June 2017 - June 2019

John Goldman Fellowship for Future Science

Public Awareness of Progeria
Funder:
Duration: -
RNA composition of exosomes as potential biomarkers for cancer
Funder: Elva-1
Duration: May 2017 - April 2019
ACBD3 as a Novel Marker and Therapeutic Target in Breast Cancer
Funder: Breast Cancer Hope
Duration: May 2017 - September 2020
Mechanistic Investigation of Histone Acetyl-transferase KAT2A in Acute Myeloid Leukaemia
Funder: Rosetrees Trust
Duration: April 2017 - March 2020

PhD studentship to Liliana Jesus Arede (University of Cambridge)

Transcriptional Heterogeneity and Gene Regulatory Networks in AML
Funder: Isaac Newton Trust
Duration: March 2017 - February 2018

Salary costs Research Associate (Dr Rashmi Kulkarni)

A human IPS cell model for gene therapy vector safety evaluation
Funder: National Centre for the Replacement, Refinement and Reduction of Animals in Research
Duration: January 2017 - December 2019

Gene therapy genotoxicity project

HBM4EU - European Human Biomonitoring Initiative
Funder: European Commission
Duration: January 2017 - December 2021
A human IPS cell model for gene therapy vector safety evaluation Phase 2
Funder: Medical Research Council
Duration: January 2017 - June 2019